PDLI Operating Expenses

Pdl Biopharma Inc · Operating Expenses

PDLI logo

PDLI Operating Expenses

Latest reported$46.37M
PDLI TTM Operating Expenses ($35.40M → $46.37M)
High-resolution chart · PNG

PDLI operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Pdl Biopharma Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
46,365,000
66,054,000
68,338,000
67,694,000
61,536,000
60,776,000
72,718,000
81,345,000
93,428,000
98,362,000
96,713,000
95,394,000
93,162,000
87,653,000
69,271,000
56,176,000
47,696,000
37,792,000
38,270,000
36,090,000
41,271,000
38,507,000
37,998,000
34,914,000
25,049,000
27,288,000
27,151,000
29,755,000
29,626,000
27,348,000
25,710,000
24,410,000
20,915,000
18,708,000
16,824,000
16,211,000
116,530,000
124,200,000
129,759,000
133,896,000
34,866,000
29,011,000
25,781,000
21,064,000
31,538,000
89,546,000
141,201,000
158,482,000
217,482,000
250,392,000
297,468,000
369,060,000
468,240,000
471,275,000
455,802,000
456,166,000
373,108,000
365,400,000
336,697,000
285,694,000
233,395,000
176,885,000
156,199,000
154,369,000
147,317,000
141,528,000
130,480,000
110,845,000
100,196,000
90,036,000
81,188,000
77,070,000
74,097,000
71,255,000
67,951,000
67,898,000
66,450,000
63,646,000
61,556,000
58,643,000
56,642,000
54,447,000
52,178,000
49,400,000
47,400,000
48,200,000
46,500,000
43,900,000
40,400,000
37,100,000
35,600,000
35,400,000
35,300,000
37,300,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.